"Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease"

Recruiting

• Conditions: Cardiovascular Diseases; Healthy

• Registration Number: NCT05472207
• Lead Sponsor: Medical University Innsbruck

Brief Summary

The aim of this study is to develop risk prediction models for the early detection of high-risk patients with structural, rhythmological or inflammatory cardiovascular diseases.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-01
• Study First Submitted: 2022-07-21
• Study First Submitted QC: 2022-07-21
• Study First Posted: 2022-07-25
• Status Verified: 2024-11
• Last Update Submitted: 2024-11-19
• Last Update Posted: 2024-11-21
• Primary Completion: 2026-01
• Study Completion: 2030-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

• Decision-eligible male and female patients ≥18 years of age
• Acute or chronic condition due to structural, rhythmologic, or inflammatory cardiovascular disease
• Informed consent for participation in the clinical trial

Exclusion Criteria

• missing infromed consent
• pregnant or breast-feeding women

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
combination of cardiovascular mortality, stroke, myocardial infarction and hospitalization due to decompensated heart failure	from inclusion to end of study (max. 4 years)

Secondary Outcome Measures

Name	Time	Method
hospitalization due to decompensated heart failure	from inclusion to end of study (max. 4 years)
severe arrythmic events	from inclusion to end of study (max. 4 years)
cardiovascular mortality	from inclusion to end of study (max. 4 years)
hospitalization due to cardiovascular condition	from inclusion to end of study (max. 4 years)
admission to intensive care unit	from inclusion to end of study (max. 4 years)
myocardial infarction	from inclusion to end of study (max. 4 years)
total mortality	from inclusion to end of study (max. 4 years)
stroke	from inclusion to end of study (max. 4 years)

Trial Locations

Locations (2)

Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin III, Kardiologie & Angiologie; 🇦🇹 Innsbruck, Tyrol, Austria

Reha Zentrum Münster; 🇦🇹 Münster, Tyrol, Austria